Helping to improve the effectiveness of healthcare and the quality of life.
Qatar Biomedical Research Institute (QBRI) is a leading research institute under Hamad Bin Khalifa University (HBKU). QBRI aims to improve and transform healthcare in Qatar through discoveries in prevention, diagnosis, and treatment of diseases affecting the people of Qatar and the region.
Dr. Lawrence Stanton
Director, Neurological Disorders Research Center
I am enthusiastic about the work we do at QBRI, which focuses on understanding neurological disorders at a fundamental level. By understanding the molecular and cellular details of conditions such as autism, we are building capacity within Qatar to improve diagnosis and develop therapies. It is an honor and privilege to be part of a multidisciplinary research team that is making an impact on patients’ lives.
Dr. Nasser Zawia
QBRI is a premier disease-focused biomedical research institute, established in alignment with the health priorities of Qatar. Its primary mission is to identify and close knowledge gaps relevant to Arab populations, which are underrepresented in the medical literature. Research at QBRI has a global impact and publication citations are among the top 1% in the world.
Dr. Paul Thornalley
Director, Diabetes Research Center
It is a privilege and honor to lead research at QBRI’s Diabetes Research Center, contributing to the Qatar national health research priority on diabetes. Our research in stem cell technology supports the development of cell therapy and mechanistic studies of diabetes. Our research on the high risk of obesity and type 2 diabetes seeks innovative solutions for screening and effective intervention, prevention, and reversal of diabetes. Our goal is to improve prevention and treatment of diabetes for the people of Qatar, with the long-term aspiration of a diabetes-free life.